Optional biopsy

PROCEDURE3 trials

Sponsors

British Columbia Cancer Agency, Washington University School of Medicine

Conditions

Borderline Resectable Pancreatic Ductal AdenocarcinomaBreast CancerBreast CarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaMalignant Neoplasm of BreastOvarian CancerOvarian NeoplasmsPancreatic Ductal Adenocarcinoma

Phase 1

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Active, not recruitingNCT02204098

Washington University School of MedicineBreast Cancer, Breast Carcinoma, Malignant Neoplasm of Breast

Start: 2015-01-07End: 2028-08-31Updated: 2025-04-17

Unknown Phase

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

TerminatedNCT01881451

British Columbia Cancer AgencyOvarian Cancer, Ovarian Neoplasms

Start: 2013-08-31End: 2020-05-31Updated: 2022-02-17

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

RecruitingNCT06574620

British Columbia Cancer AgencyBorderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma +1

Start: 2025-11-28End: 2031-12-01Target: 200Updated: 2026-01-16